Gainesville, FL, United States of America

Marc S Cohen


Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 282(Granted Patents)


Company Filing History:


Years Active: 1996-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Marc S. Cohen in Controlled Release Technologies

Introduction

Marc S. Cohen is an accomplished inventor based in Gainesville, Florida. He has made significant contributions to the field of controlled release technologies, holding a total of four patents. His work focuses on developing innovative methods and devices that enhance the delivery of biologically active agents.

Latest Patents

One of Marc S. Cohen's latest patents involves compositions and devices for the controlled release of active ingredients. This method utilizes a hydrophobic, pH-sensitive polymer matrix that releases the active agent when the environment reaches a pH of 8.5. The polymer matrix swells in response to this pH change, allowing for the gradual release of the active agent. In another embodiment, the system employs weakly basic comonomers, releasing the active agent as the pH drops. A specific application of this technology is in ureteral catheterization, where the pH-sensitive polymer is coated onto latex catheters. This innovation addresses the common issue of urinary tract infections caused by urease-producing bacteria in catheterized patients. The polymer can release an antibiotic or urease inhibitor when exposed to high pH urine, maintaining effective drug levels for a clinically useful duration. Other potential applications for this technology include gastrointestinal tubes, respiratory trap lines, dye-releasing sutures, and even contact lenses.

Career Highlights

Marc S. Cohen is associated with Caphco, Inc., where he continues to develop and refine his innovative technologies. His work has garnered attention for its practical applications in medical devices and other fields.

Collaborations

Marc has collaborated with notable colleagues, including Christopher D. Batich and Kirk Foster, to advance his research and development efforts.

Conclusion

Marc S. Cohen's contributions to controlled release technologies exemplify the impact of innovative thinking in addressing real-world challenges. His patents reflect a commitment to improving patient care and enhancing the functionality of medical devices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…